Metastatic ER+ Breast Cancer: Mechanisms of Resistance and Future Therapeutic Approaches

Endocrine therapy is the main treatment for hormone receptor-positive (HR+) breast cancer. However, advanced tumors develop resistance to endocrine therapy, rendering it ineffective as the disease progresses. There are several molecular mechanisms of primary and secondary endocrine resistance. Resis...

Descripción completa

Detalles Bibliográficos
Autores principales: Raheem, Farah, Karikalan, Suganya Arunachalam, Batalini, Felipe, El Masry, Aya, Mina, Lida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671474/
https://www.ncbi.nlm.nih.gov/pubmed/38003387
http://dx.doi.org/10.3390/ijms242216198